S. Abgrall

发表

Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV

D. Costagliola, S. Grabar, G. Pialoux, 2009, AIDS.

Impact of Late Presentation on the Risk of Death Among HIV-Infected People in France (2003–2009)

M. Guiguet, D. Costagliola, S. Grabar, 2013, Journal of acquired immune deficiency syndromes.

Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients

J. Sterne, A. Mocroft, A. d’Arminio Monforte, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sterne, J. A. C. (2020). Cause-specific mortality after diagnosis of cancer among HIV-positive patients: a collaborative analysis of cohort

J. Sterne, P. Reiss, M. Gill, 2020 .

Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies

J. Sterne, A. d’Arminio Monforte, P. Reiss, 2020, International journal of cancer.

Risk of tuberculosis following HIV seroconversion in high-income countries

C. Morrison, A. d’Arminio Monforte, C. Sabin, 2012, Thorax.

Access to the waiting list and to kidney transplantation for people living with HIV: A national registry study

S. Tezenas du Montcel, M. Guiguet, D. Costagliola, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older

M. Hernán, C. Sabin, A. Phillips, 2017, Journal of acquired immune deficiency syndromes.

Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.

Richard D Moore, J. Robins, M. Hernán, 2016, International journal of epidemiology.

Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.

Jessica G. Young, M. Hernán, J. Sterne, 2015, The lancet. HIV.

Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002–2009

J. Sterne, P. Reiss, T. Sterling, 2012, AIDS.

Does region of origin influence the timing and outcome of first‐line antiretroviral therapy in France?

W. Rozenbaum, S. Diamantis, J. Molina, 2018, HIV Medicine.

AMultifaceted Intervention Designed to Improve Medical Management of Moderate to Advanced Chronic Kidney Disease in HIV-Infected Patients: A Cluster Randomized Trial

M. Guiguet, P. Durieux, D. Costagliola, 2015 .

A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial.

M. Guiguet, P. Durieux, D. Costagliola, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis

J. Sterne, T. Sterling, M. May, 2013, AIDS.

Spondylitis Due to Mycobacterium xenopi in a Human Immunodeficiency Virus Type 1-Infected Patient: Case Report and Review of the Literature

H. Adle-Biassette, P. Yeni, G. Hayem, 2005, Journal of Clinical Microbiology.

Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France

D. Costagliola, S. Grabar, O. Launay, 2018, PloS one.

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.

Richard D Moore, J. Robins, M. Hernán, 2017, The lancet. HIV.

Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France

D. Costagliola, S. Grabar, O. Launay, 2016, AIDS.

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

J. Robins, M. Hernán, J. Sterne, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study

J. Robins, M. Hernán, J. Sterne, 2012, AIDS.

Multidrug-resistant chronic osteomyelitis complicating war injury in Iraqi civilians.

D. Anderson, S. Abgrall, R. M. Fakhri, 2011, The Journal of trauma.

Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients.

E. Vicaut, G. Carcelain, B. Autran, 2008, Tuberculosis.

Isoniazid-monoresistant tuberculosis in France: risk factors, treatment outcomes and adverse events.

Y. Yazdanpanah, C. Londner, B. Fantin, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Clinical and immunologic outcome in patients with human immunodeficiency virus infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy.

D. Costagliola, D. Descamps, V. Joly, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes

J. Robins, M. Hernán, J. Sterne, 2016, Medicine.

Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir.

C. Katlama, D. Costagliola, C. Pradier, 2011, The Journal of antimicrobial chemotherapy.

Risk Factors for Esophageal Candidiasis in a Large Cohort of HIV-Infected Patients Treated with Nucleoside Analogues

P. Yeni, J. Reynes, S. Abgrall, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Sleeve Gastrectomy Is a Safe and Efficient Procedure in HIV Patients with Morbid Obesity: a Case Series with Results in Weight Loss, Comorbidity Evolution, CD4 Count, and Viral Load

J. Catheline, M. Bekheit, S. Abgrall, 2015, Obesity Surgery.

Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4

D. Costagliola, S. Grabar, G. Pialoux, 2017, PLoS ONE.

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

G. Canonica, T. Zander, N. Adhikari, 2021, The Lancet Respiratory Medicine.

HIV is associated with airway obstruction: a matched controlled study

M. Zins, S. Eymard-Duvernay, F. Raffi, 2017, AIDS.

High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers

S. Eymard-Duvernay, F. Raffi, F. Bonnet, 2014, European Respiratory Journal.

HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data)

M. Ziol, C. Delaugerre, C. Katlama, 2022, AIDS Research and Therapy.

Lactobacillus casei infection in an AIDS patient

Claude Carbón, P. Derkinderen, P. Yeni, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe

A. Mocroft, O. Kirk, C. Sabin, 2017, AIDS.

Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.

Ross J. Harris, J. Sterne, A. Mocroft, 2008, Antiviral therapy.

A lupus-like glomerulonephritis following acute HIV-1 seroconversion in an African woman.

T. Papo, S. Abgrall, M. Matignon, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France

D. Costagliola, S. Grabar, O. Launay, 2015, PloS one.

Early prosthetic valve endocarditis due to Staphylococcus warneri with negative blood culture.

J. Mainardi, L. Gutmann, A. Buu-Hoi, 2001, The Journal of infection.

Silicone in HIV-1-infected patients: a cause of misdiagnosed granulomatous disease.

H. Adle-Biassette, P. Yeni, N. Leboulanger, 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients.

J. Sterne, O. Kirk, A. d’Arminio Monforte, 2014, AIDS.

Impact of vaccination on the presence and severity of symptoms of hospitalised patients with an infection by the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1).

G. Béraud, J. Faucher, S. Abgrall, 2022, medRxiv.

Comparative eff ectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study

J. Sterne, C. Sabin, H. Furrer, 2015 .

Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4)

C. Katlama, H. Melliez, M. Guiguet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?

D. Costagliola, A. Balde, S. Abgrall, 2020, PloS one.

Risk factors for loss to follow‐up, transfer or death among people living with HIV on their first antiretroviral therapy regimen in Mali

D. Costagliola, A. Balde, S. Abgrall, 2018, HIV medicine.

Prognostic importance of anaemia in HIV-1 infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies in industrialized countries

J. Sterne, A. Mocroft, M. Egger, 2015 .

Hospitalization criteria in imported falciparum malaria.

J. Le bras, J. Tourret, S. Abgrall, 2007, Journal of travel medicine.

High-flow cannula for frail patients with SARS-CoV-2 infection non-eligible for intensive care unit management

M. Martinot, S. Abgrall, L. Lemonnier, 2022, Infectious Diseases Now.

Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.

F. Batteux, S. Grabar, P. Lebon, 2015, Vaccine.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.

D. Costagliola, S. Abgrall, C. Rabaud, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.

B. Gazzard, A. Mocroft, O. Kirk, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prognostic Importance of Anaemia in HIV Type-1-Infected Patients Starting Antiretroviral Therapy: Collaborative Analysis of Prospective Cohort Studies

Ross J. Harris, J. Sterne, A. Mocroft, 2008, Antiviral Therapy.

Scedosporium apiospermum lung infection with fatal subsequent postoperative outcome in an immunocompetent host.

Antoine Martin, O. Lortholary, E. Martinod, 2007, Clinical Infectious Diseases.

Cerebral thrombophlebitis as a paradoxical reaction in HIV-patients.

V. Prendki, A. Boch, J. Dumas, 2008, AIDS.

Factors Associated with HIV Status Disclosure in HIV-Infected Sub-Saharan Migrants Living in France and Successfully Treated with Antiretroviral Therapy: Results from the ANRS-VIHVO Study

M. Carrieri, B. Spire, D. Bourgeois, 2017, Journal of Immigrant and Minority Health.

Neurologic manifestations associated with COVID-19: a multicentre registry

L. Defebvre, G. Béraud, G. Edan, 2020, Clinical Microbiology and Infection.

Long-Term Persistence of Humoral Immunity After Hepatitis A Vaccination in HIV-Infected Adults

P. Böelle, S. Kernéis, S. Grabar, 2011, Journal of acquired immune deficiency syndromes.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers

S. Eymard-Duvernay, F. Raffi, F. Bonnet, 2016, AIDS.

CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3

G. Carcelain, Y. Yazdanpanah, M. Guiguet, 2008, Antiviral therapy.

Early prosthetic joint infection due to Ureaplasma urealyticum: Benefit of 16S rRNA gene sequence analysis for diagnosis.

F. Doucet-Populaire, S. Abgrall, S. Pereyre, 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Phylogroup stability contrasts with high within sequence type complex dynamics of Escherichia coli bloodstream infection isolates over a 12-year period

E. Denamur, F. Tubach, X. Panhard, 2021, Genome medicine.

Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.

C. Leport, S. Pavy, X. Duval, 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Effect of sociodemographic factors on survival of people living with HIV

S. Abgrall, J. Del Amo, 2016, Current opinion in HIV and AIDS.

Dual Nucleoside Reverse Transcriptase Inhibitor Therapy in the Combination Antiretroviral Therapy Era and Predictors of Discontinuation or Switch to Combination Antiretroviral Therapy

D. Costagliola, A. Mahamat, H. Selinger-Leneman, 2008, Journal of acquired immune deficiency syndromes.

Comparative Effectiveness of Initial Antiretroviral Therapy Regimens: ACTG 5095 and 5142 Clinical Trials Relative to ART-CC Cohort Study

Ross J. Harris, R. Haubrich, J. Sterne, 2011, Journal of acquired immune deficiency syndromes.

The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis

O. Kirk, A. d’Arminio Monforte, R. Weber, 2012, HIV medicine.

The Incidence of AIDS-De fi ning Illnesses at a Current CD 4 Count ≥ 200 Cells / μ L in the Post – Combination Antiretroviral Therapy Era

B. Gazzard, A. Mocroft, O. Kirk, 2013 .

Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4).

C. Katlama, M. Guiguet, D. Costagliola, 2014, International journal of epidemiology.

Increased non‐AIDS mortality among persons with AIDS‐defining events after antiretroviral therapy initiation

J. Sterne, J. Miro, P. Reiss, 2018, Journal of the International AIDS Society.

Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).

M. Ziol, V. Paradis, C. Delaugerre, 2020, Journal of hepatology.

T Cells δγ and KIR-Negative Involves Tuberculin-Specific CD 4 Th 1 Cells Syndrome in HIV-1-Infected Patients Tuberculosis-Associated Immune Restoration Autran

E. Vicaut, G. Carcelain, A. Samri, 2009 .

Factors Associated with Virological Rebound in HIV-Positive Sub-Saharan Migrants Living in France After Traveling Back to Their Native Country: ANRS-VIHVO 2006–2009 Study

M. Guiguet, M. Carrieri, B. Spire, 2019, Journal of Immigrant and Minority Health.

D. Malvy, A. Duvignaud, D. Gabillard, 2019, Travel medicine and infectious disease.

Symptoms and severity in vaccinated and unvaccinated patients hospitalised with SARS-CoV-2 delta (B.1.617.2) variant infection

G. Béraud, P. Casez, A. Mahamat, 2022, medRxiv.

Visiting One’s Native Country

B. Spire, P. Carrieri, L. Fugon, 2013, Journal of the International Association of Providers of AIDS Care.

Tuberculosis-Associated Immune Restoration Syndrome in HIV-1-Infected Patients Involves Tuberculin-Specific CD4 Th1 Cells and KIR-Negative γδ T Cells1

E. Vicaut, G. Carcelain, A. Samri, 2009, The Journal of Immunology.

Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection

G. Béraud, P. Casez, J. Faucher, 2022, Clinical Microbiology and Infection.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Parameter estimates for trends and patterns of excess mortality among persons on ART in high-income european settings.

J. Sterne, M. Gill, M. Cavassini, 2019, AIDS.

Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings

J. Sterne, A. d’Arminio Monforte, M. Gill, 2019, AIDS.

Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.

S. Kernéis, C. Couzigou, V. Manceron, 2023, Journal of Antimicrobial Chemotherapy.

Factors associated with hospital admission and adverse outcome for COVID-19: Role of social factors and medical care

S. Abgrall, J. Teglas, C. Guillet-Caruba, 2022, Infectious Diseases Now.

Effect estimates in randomized trials and observational studies: comparing apples with apples.

Haitao Chu, Kholoud Porter, Stephen R Cole, 2019, American journal of epidemiology.

Modeling the Time Course of CD4 T-Lymphocyte Counts According to the Level of Virologic Rebound in HIV-1–Infected Patients on Highly Active Antiretroviral Therapy

D. Costagliola, D. Descamps, X. Duval, 2003, Journal of acquired immune deficiency syndromes.

HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years

D. Costagliola, S. Abgrall, G. Melica, 2010, AIDS.

When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study

J. Robins, M. Hernán, S. Hernández-Díaz, 2016, Journal of acquired immune deficiency syndromes.

Mortality of people living with HIV in Paris Area from 2011 to 2015.

W. Rozenbaum, J. Molina, P. Sellier, 2020, AIDS research and human retroviruses.

Elevated Risk of Viral Rebound on ART in Migrants Living in France: Role of Socioeconomic Factors

L. Meyer, G. Pialoux, C. Goujard, 2019, Antiviral therapy.

Respective roles of migration and social deprivation for virological non-suppression in HIV-infected adults on antiretroviral therapy in France

M. Guiguet, C. Michaud, M. Favier, 2019, PloS one.

Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV‐positive individuals

Richard D Moore, J. Robins, M. Hernán, 2019, Statistics in medicine.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency.

D. Costagliola, S. Grabar, A. Mahamat, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk of Severe Bacterial Infection in People Living Human Immunodeficiency Virus Infection in the Combined Antiretroviral Therapy Era

H. Melliez, M. Guiguet, D. Costagliola, 2020 .

Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir

D. Costagliola, P. Yeni, S. Abgrall, 2006, AIDS.

Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives.

Y. Yazdanpanah, F. Raffi, L. Meyer, 2017, AIDS.

Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort.

C. Katlama, H. Melliez, D. Costagliola, 2023, The Journal of antimicrobial chemotherapy.

Influence of geographical origin and ethnicity on mortality in patients on antiretroviral therapy in Canada, Europe, and the United States.

J. Sterne, D. Podzamczer, F. Lampe, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies.

J. Sterne, A. d’Arminio Monforte, C. Rentsch, 2023, Journal of viral hepatitis.

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.

M. Hernán, J. Sterne, C. Sabin, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case–Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4)

D. Costagliola, Jean‐Marc Lacombe, M. Valantin, 2019, Journal of acquired immune deficiency syndromes.

Initial strategy for antiretroviral-naive patients

S. Abgrall, 2006, The Lancet.

Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort

M. Ziol, C. Delaugerre, C. Katlama, 2020 .

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

J. Sterne, A. Sabin, A. Mocroft, 2018, HIV medicine.

Lack of Effect of Doxycycline on Trough Concentrations of Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients

G. Peytavin, F. Mentré, S. Abgrall, 2013, HIV clinical trials.

Does enfuvirtide increase the risk of bacterial pneumonia in patients receiving combination antiretroviral therapy?

D. Costagliola, O. Launay, S. Abgrall, 2010, The Journal of antimicrobial chemotherapy.

A delayed immune reconstitution inflammatory syndrome.

M. Brauner, J. Cailhol, S. Abgrall, 2007, AIDS.

Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir.

D. Costagliola, P. Yeni, S. Abgrall, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions

M. Hernán, A. Winston, C. Sabin, 2017, Journal of acquired immune deficiency syndromes.

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

M. Ziol, C. Delaugerre, C. Katlama, 2022, JHEP reports : innovation in hepatology.

[Recent data from the literature on the biological and pathologic effects of electromagnetic radiation, radio waves and stray currents].

S. Abgrall, A. Bravo‐Cuellar, S. Orbach-Arbouys, 1999, Pathologie-biologie.

Infectious encephalitis in elderly patients: a prospective multicentre observational study in France 2016–2019

S. Rheims, C. Diard-Detoeuf, N. Girard, 2022, Infection.

Factors associated with being overweight and obesity in people living with HIV on antiretroviral therapy : socio-clinical, inflammation, and metabolic markers.

A. Maignan, Y. Yazdanpanah, D. Neau, 2021, The Journal of infectious diseases.

Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1)

G. Béraud, J. Faucher, S. Abgrall, 2022, Clinical Microbiology and Infection.